Home/Clinical Practice/FDA Approves Self-Administered Nasal Flu…Clinical PracticeSeptember 23, 2024FDA Approves Self-Administered Nasal Flu Vaccine, Expanding Access and ConvenienceBy Richard Waithe, PharmD#Drug Safety & Recalls#FDA ApprovalsKeep readingRelated ArticlesClinical PracticeLilly Launches Zepbound KwikPen: A Multi-Dose Monthly Option for Weight ManagementClinical PracticeFDA Approves YUVEZZI: First Dual-Agent Eye Drop for Age-Related Near Vision LossClinical PracticeGabapentin Linked to Dementia Risk: What Pharmacists Need to Know